All questionsSafety: Xolair (omalizumab), all indications9 questions · 2 sourcesWarningsCan Xolair cause anaphylaxis (boxed warning)?“WARNING: Anaphylaxis” (opens the source at this quote in a new tab)CopyFlag“Anaphylaxis presenting as bronchospasm, hypotension, syncope, urticaria, and/or angioedema of the throat or tongue, has been reported to occur after administration of XOLAIR. Anaphylaxis has occurred as early as after the first dose of XOLAIR, but also has occurred beyond 1 year after beginning regularly administered treatment. Because of the risk of anaphylaxis, initiate XOLAIR therapy in a healthcare setting and closely observe patients for an appropriate period of time after XOLAIR administration. Health care providers administering XOLAIR should be prepared to manage anaphylaxis which can be life-threatening. Inform patients of the signs and symptoms of anaphylaxis and instruct them to seek immediate medical care should symptoms occur. Selection of patients for self-administration of XOLAIR should be based on criteria to mitigate risk from anaphylaxis.” (opens the source at this quote in a new tab)CopyFlagWhen does anaphylaxis happen after a Xolair dose?“In premarketing clinical trials in patients with asthma, anaphylaxis was reported in 3 of 3507 (0.1%) patients. Anaphylaxis occurred with the first dose of XOLAIR in two patients and with the fourth dose in one patient. The time to onset of anaphylaxis was 90 minutes after administration in two patients and 2 hours after administration in one patient.” (opens the source at this quote in a new tab)CopyFlag“Approximately 60% to 70% of anaphylaxis cases have been reported to occur within the first three doses of XOLAIR, with additional cases occurring sporadically beyond the third dose.” (opens the source at this quote in a new tab)CopyFlag“There have been reports of anaphylaxis occurring up to 4 days after administration of XOLAIR” (opens the source at this quote in a new tab)CopyFlagWho is at higher risk of anaphylaxis with Xolair?“A case-control study in asthma patients showed that, among XOLAIR users, patients with a history of anaphylaxis to foods, medications, or other causes were at increased risk of anaphylaxis associated with XOLAIR, compared to those with no prior history of anaphylaxis.” (opens the source at this quote in a new tab)CopyFlag“The study found that a self-reported history of anaphylaxis to foods, medications or other causes was more common among patients with XOLAIR anaphylaxis (57% of 30 cases) compared to controls (23% of 88 controls) [OR 8.1, 95% CI 2.7 to 24.3].” (opens the source at this quote in a new tab)CopyFlagWhat are the contraindications for Xolair?“XOLAIR is contraindicated in patients with a severe hypersensitivity reaction to XOLAIR or to any ingredient of XOLAIR.” (opens the source at this quote in a new tab)CopyFlag“Discontinue XOLAIR in patients who experience a severe hypersensitivity reaction.” (opens the source at this quote in a new tab)CopyFlagCan Xolair cause fever, joint pain, and rash (serum sickness)?“Fever, Arthralgia, and Rash: In post-approval use, some patients have experienced a constellation of signs and symptoms, including arthritis/arthralgia, rash, fever, and lymphadenopathy with an onset 1 to 5 days after the first or subsequent injections of XOLAIR. These signs and symptoms have recurred after additional doses in some patients. Physicians should stop XOLAIR if a patient develops this constellation of signs and symptoms.” (opens the source at this quote in a new tab)CopyFlagDoes Xolair increase the risk of parasitic worm infections?“Parasitic (Helminth) Infection: Monitor patients at high risk of geohelminth infection while on XOLAIR therapy. Insufficient data are available to determine the length of monitoring required for geohelminth infections after stopping XOLAIR treatment.” (opens the source at this quote in a new tab)CopyFlag“In a one-year clinical trial conducted in Brazil in adult and adolescent patients at high risk for geohelminthic infections (roundworm, hookworm, whipworm, threadworm), 53% (36/68) of XOLAIR-treated patients experienced an infection, as diagnosed by standard stool examination, compared to 42% (29/69) of placebo controls. The point estimate of the odds ratio for infection was 1.96, with a 95% confidence interval (0.88, 4.36) indicating that in this study a patient who had an infection was anywhere from 0.88 to 4.36 times as likely to have received XOLAIR than a patient who did not have an infection. Response to appropriate anti-geohelminth treatment of infection as measured by stool egg counts was not different between treatment groups.” (opens the source at this quote in a new tab)CopyFlagCan Xolair be used as an emergency treatment for allergic reactions?“Potential Medication Error Related to Emergency Treatment of Anaphylaxis: XOLAIR should not be used for the emergency treatment of allergic reactions, including anaphylaxis. In studies to simulate use, some patients and caregivers did not understand that XOLAIR is not intended for the emergency treatment of allergic reactions, including anaphylaxis. The safety and effectiveness of XOLAIR for emergency treatment of allergic reactions, including anaphylaxis, have not been established.” (opens the source at this quote in a new tab)CopyFlagSide effectsCan Xolair cause hair loss?“The following adverse reactions have been identified during postapproval use of XOLAIR. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.” (opens the source at this quote in a new tab)CopyFlag“Skin: Hair loss has been reported.” (opens the source at this quote in a new tab)CopyFlagSafetyHow do I report Xolair side effects?“You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555 or Novartis Pharmaceuticals Corporation at (888) 669-6682.” (opens the source at this quote in a new tab)CopyFlag